| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.00081 |
1 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.05 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.02 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |